FIELD: medicine, cardiology. SUBSTANCE: method involves determination of increase of 2-thiobarbituric active compounds (malonic dialdehyde), cholesterol level in high density lipoproteins and lag-period. On the basis of value and ratio of investigated indices blood total antioxidant activity is evaluated as high, moderate or low. EFFECT: increased precision, decreased time of analysis. 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROGNOSIS OF ISCHEMIC HEART DISEASE COURSE | 1995 |
|
RU2102756C1 |
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC DISEASE TREATMENT | 1995 |
|
RU2122732C1 |
METHOD OF DETERMINATION OF BLOOD LIPOPROTEID FRACTIONS IN PATIENTS WITH HEART ISCHEMIC DISEASE | 2000 |
|
RU2200950C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210078C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210076C2 |
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210075C2 |
METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210077C2 |
METHOD OF DETERMINATION OF BLOOD MODIFIED LIPOPROTEIN FRACTIONS | 2000 |
|
RU2210079C2 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2462722C1 |
Authors
Dates
1998-07-27—Published
1995-05-22—Filed